Table 2: Incidences of Adverse Reactions and marked laboratory abnormalities from the phase II
Tabell 2: Förekomsten av biverkningar och uttalade avvikande laboratorieresultat i fas II
Laboratory abnormalities should be managed with dose reduction,
Avvikande laboratorievärden ska hanteras genom dosreduktion, behandlingsuppehåll
Table 2: Incidences of Adverse Reactions and marked laboratory abnormalities in clinical studies
Tabell 2: Förekomst av biverkningar och påtagliga avvikelser i laboratorievärdeni kliniska studier
Most laboratory abnormalities noted during the clinical trial returned to baseline levels shortly after discontinuation of treatment.
De flesta laboratorieavvikelser som noterades under den kliniska studien återvände kort efter behandlingsavslut till samma nivåer som vid studiestart.
Myelosuppression was reported in patients with normal baseline laboratory values as well as in patients with pre-existing laboratory abnormalities.
Myelosuppression rapporterades hos patienter med normala laboratorievärden vid baslinjen liksom hos patienter med redan tidigare avvikande laboratorievärden.
Incidence of laboratory abnormalities in TT01 and TT02 n=80 patients.
Incidens av avvikande laboratorievärden i TT01 och TT02 n=80 patienter.
venous thromboembolic events and laboratory abnormalities hypomagnesaemia and albumin-corrected hypocalcaemia.
venösa tromboemboliska händelser och avvikande laboratorievärden hypomagnesemi och albuminkorrigerad hypokalcemi.
All symptoms and laboratory abnormalities resolved without treatment after discontinuation of the study medicinal product.
Alla symtom och onormala laboratorievärden avklingade utan behandling efter utsättande av studieläkemedlet.
In treatment-naïve patients, the incidence of grade 3 and 4 laboratory abnormalities using ACTG criteria was similar among the maraviroc
För behandlingsnaiva patienter var incidensen onormala laboratorievärden av grad 3 och 4, vid användande av ACTG-kriterier, lika för behandlingsgrupperna
Laboratory abnormalities were reported as adverse events less frequently by investigators than as indicated by laboratory value tables.
Onormala laboratorievärden rapporterades mindre frekvent som biverkningar av prövarna än vad som framgår av tabellerna över laboratorievärdena.
paraesthesia) and laboratory abnormalities(elevated liver enzymes)
parestesi) och avvikelser i laboratorievärden(förhöjda leverenzymer)
Laboratory abnormalities in liver function tests have been seen in healthy volunteers
Laboratorieavvikelser i leverfunktionstester har setts hos friska försökspersoner samt hos patienter, vuxna
The list also includes marked laboratory abnormalities that have been observed with nelfinavir at 48 weeks.
Listan inkluderar även uttalade avvikande laboratorieresultat som har observerats med nelfinavir efter 48 veckor.
Table 7 Laboratory abnormalities observed in patients treated with trastuzumab emtansine in study TDM4370g/BO21977.
Tabell 7 Onormala laboratorievärden observerade hos patienter behandlade med trastuzumab emtansin i studie TDM4370g/BO21977.
The incidence of adverse events and laboratory abnormalities(with the exception of elevations of ALT
Förekomsten av medicinska incidenter och laboratorieavvikelser(med undantag av förhöjning av ALAT
Laboratory abnormalities Table 5 shows the incidence≥ 1% of Grade 3-4 Abnormalities(ACTG Criteria)
Onormala laboratorievärden Tabell 5 visar incidensen ≥1% för onormala värden grad 3- 4(ACTG- kriteria),
Results: 93,
Time: 0.0565
How to use "laboratory abnormalities" in an English sentence
Clinically significant laboratory abnormalities were identified by the Investigator.
What other laboratory abnormalities are common with parasitic infections?
Laboratory abnormalities return to normal as the condition resolves.
Laboratory abnormalities include thrombocytopenia, leukopenia, and elevated liver tests.
Observed laboratory abnormalities were comparable to those in adults.
No other laboratory abnormalities or syndromic features were evident.
Introduction laboratory abnormalities and the progressiveness of the symptoms.
The observed nonhematologic laboratory abnormalities were mainly grade 1/2.
Laboratory abnormalities include anemia, thrombocytopenia, and elevated hepatic transaminases.
Laboratory diagnosis No laboratory abnormalities can be expected (4.
Svenska
Deutsch
Suomi
Français
Norsk
عربى
Български
বাংলা
Český
Dansk
Ελληνικά
Español
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
日本語
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt
中文